{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T08:56:16Z","timestamp":1794646576246,"version":"4.9.1"},"reference-count":21,"publisher":"National Center for Global Health and Medicine (JST)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["GHM"],"published-print":{"date-parts":[[2023,12,31]]},"DOI":"10.35772\/ghm.2023.01051","type":"journal-article","created":{"date-parts":[[2023,11,26]],"date-time":"2023-11-26T22:12:31Z","timestamp":1701036751000},"page":"362-365","source":"Crossref","is-referenced-by-count":6,"title":["Clinical features and treatment outcomes of Fournier's gangrene in a single tertiary emergency hospital: Simplified Fournier's Gangrene Severity Index score is a predictor for death"],"prefix":"10.35772","volume":"5","author":[{"given":"Taichi","family":"Shiratori","sequence":"first","affiliation":[{"name":"Department of Urology, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Urology, NTT Medical Center Tokyo, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Naito","sequence":"additional","affiliation":[{"name":"Department of Urology, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Urology, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Okura","sequence":"additional","affiliation":[{"name":"Tertiary Emergency Medical Center, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yamakawa","sequence":"additional","affiliation":[{"name":"Tertiary Emergency Medical Center, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruki","family":"Kume","sequence":"additional","affiliation":[{"name":"Department of Urology, The University of Tokyo Hospital, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motofumi","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Urology, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"21485","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Hagedorn JC, Wessells H. A contemporary update on Fournier&apos;s gangrene. Nat Rev Urol. 2017; 14:205-214.","DOI":"10.1038\/nrurol.2016.243"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Bowen D, Julieb\u00f8-Jones P, Somani BK. Global outcomes and lessons learned in the management of Fournier&apos;s gangrene from high-volume centres: Findings from a literature review over the last two decades. World J Urol. 2022; 40:2399-2410.","DOI":"10.1007\/s00345-022-04139-4"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Sorensen MD, Krieger JN. Fournier&apos;s Gangrene: Epidemiology and outcomes in the general US population. Urol Int. 2016; 97:249-259.","DOI":"10.1159\/000445695"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Lin TY, Su CC, Chang YC, Chen IH, Ou CH, Cheng YS. The sufficient multidisciplinary specialists under a government-led health care system associated with the downward mortality trend of Fournier&apos;s gangrene in Taiwan. Int J Urol. 2023; 30:182-189.","DOI":"10.1111\/iju.15081"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Sugihara T, Yasunaga H, Horiguchi H, Fujimura T, Ohe K, Matsuda S, Fushimi K, Homma Y. Impact of surgical intervention timing on the case fatality rate for Fournier&apos;s gangrene: an analysis of 379 cases. BJU Int. 2012; 110:E1096-E1100.","DOI":"10.1111\/j.1464-410X.2012.11291.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Laor E, Palmer LS, Tolia BM, Reid RE, Winter HI. Outcome prediction in patients with Fournier&apos;s gangrene. J Urol. 1995; 154:89-92.","DOI":"10.1016\/S0022-5347(01)67236-7"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Gawande AA, Kwaan MR, Regenbogen SE, Lipsitz SA, Zinner MJ. An Apgar score for surgery. J Am Coll Surg. 2007; 204:201-208.","DOI":"10.1016\/j.jamcollsurg.2006.11.011"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Yilmazlar T, Ozturk E, Ozguc H, Ercan I, Vuruskan H, Oktay B. Fournier&apos;s gangrene: an analysis of 80 patients and a novel scoring system. Tech Coloproctol. 2010; 14:217-223.","DOI":"10.1007\/s10151-010-0592-1"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40:373-383.","DOI":"10.1016\/0021-9681(87)90171-8"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Arora A, Rege S, Surpam S, Gothwal K, Narwade A. Predicting mortality in fournier gangrene and validating the Fournier Gangrene Severity Index: Our experience with 50 patients in a tertiary care center in India. Urol Int. 2019; 102:311-318.","DOI":"10.1159\/000495144"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Selvi I, Aykac A, Baran O, Burlukkara S, Ozok U, Sunay MM. A different perspective for morbidity related to Fournier&apos;s gangrene: Which scoring system is more reliable to predict requirement of skin graft and flaps in survivors of Fournier&apos;s gangrene? Int Urol Nephrol. 2019; 51:1303-1311.","DOI":"10.1007\/s11255-019-02188-0"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Sparenborg JD, Brems JA, Wood AM, Hwang JJ, Venkatesan K. Fournier&apos;s gangrene: a modern analysis of predictors of outcomes. Transl Androl Urol. 2019; 8:374-378.","DOI":"10.21037\/tau.2019.03.09"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ten\u00f3rio CEL, Lima SVC, Albuquerque AV, Cavalcanti MP, Teles F. Risk factors for mortality in fournier&apos;s gangrene in a general hospital: Use of simplified founier gangrene severe index score (SFGSI). Int Braz J Urol. 2018; 44:95-101.","DOI":"10.1590\/s1677-5538.ibju.2017.0193"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Sakamoto A, Kaneko T, Kanatani A, Kimura M, Takahashi S, Yamada Y, Miyake Y, Sakamoto T, Nakagawa T. Fournier gangrene: an analysis of 15 cases. Nihon Hinyokika Gakkai Zasshi. 2021; 112:65-69. (in Japanese)","DOI":"10.5980\/jpnjurol.112.65"},{"key":"15","unstructured":"15. Bonkat G, Bartoletti R, Bruyere F. EAU Guidelines on Urological Infections. <i>https:\/\/uroweb.org\/guidelines\/urological-infections\/related-content<\/i> (accessed April 15, 2023)"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Lin TY, Ou CH, Tzai TS, Tong YC, Chang CC, Cheng HL, Yang WH, Lin YM. Validation and simplification of Fournier&apos;s gangrene severity index. Int J Urol. 2014; 21:696-701.","DOI":"10.1111\/iju.12426"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Jahir T, Hossain S, Bagum M, Saidi A, Risal R, Schmidt M.A rare but life-threatening case of fournier&apos;s gangrene caused by sodium-glucose cotransporter-2 (SGLT2) inhibitor, empagliflozin. Cureus. 2022; 14:e29264.","DOI":"10.7759\/cureus.29264"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Serrano Olave A, Bueno Moral AI, Mart\u00ednez Ba\u00f1\u00f3n C, Gonz\u00e1lez Mesa E, Jim\u00e9nez L\u00f3pez JS. Fournier&apos;s gangrene under sodium-glucose cotransporter-2 inhibitors therapy in gynecological patients. Int J Environ Res Public Health. 2022; 19:6261.","DOI":"10.3390\/ijerph19106261"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Tuncel A, Keten T, Aslan Y, Kayali M, Erkan A, Koseoglu E, Atan A. Comparison of different scoring systems for outcome prediction in patients with Fournier&apos;s gangrene: experience with 50 patients. Scand J Urol. 2014; 48:393-399.","DOI":"10.3109\/21681805.2014.886289"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Erol B, Tuncel A, Tok A, Hanci V, Sari U, Sendogan F, Budak S, Aydemir H, Amasyali AS, Yildirim A, Caskurlu T. Low magnesium levels an important new prognostic parameter can be overlooked in patients with Fournier&apos;s gangrene: A multicentric study. Int Urol Nephrol. 2015; 47:1939-1945.","DOI":"10.1007\/s11255-015-1131-9"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Roghmann F, von Bodman C, L\u00f6ppenberg B, Hinkel A, Palisaar J, Noldus J. Is there a need for the Fournier&apos;s gangrene severity index? Comparison of scoring systems for outcome prediction in patients with Fournier&apos;s gangrene. BJU Int. 2012; 110:1359-1365.","DOI":"10.1111\/j.1464-410X.2012.11082.x"}],"container-title":["Global Health &amp; Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ghm\/5\/6\/5_2023.01051\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T04:04:40Z","timestamp":1704513880000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ghm\/5\/6\/5_2023.01051\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,31]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.35772\/ghm.2023.01051","relation":{},"ISSN":["2434-9186","2434-9194"],"issn-type":[{"value":"2434-9186","type":"print"},{"value":"2434-9194","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,31]]},"article-number":"2023.01051"}}